Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study.
Saved in:
| Title: | Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study. |
|---|---|
| Authors: | Ndiaye BP; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Koech L; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya., Mercer LD; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Aponte JJ; PATH Center for Vaccine Innovation and Access, Geneva, Switzerland., Cisse B; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Riziki F; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya., Keter W; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya., Eaton N; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Diye S; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Wade D; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal., Bob NS; Institut Pasteur de Dakar, Dakar, Senegal., Raine MG; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Her H; EuBiologics, Seoul, South Korea., Kim S; EuBiologics, Seoul, South Korea., Erdem R; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Lee C; EuBiologics, Seoul, South Korea., Cassels FJ; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Park Y; EuBiologics, Seoul, South Korea., Dia M; Institut Pasteur de Dakar, Dakar, Senegal., Baik YO; EuBiologics, Seoul, South Korea., Fall G; Institut Pasteur de Dakar, Dakar, Senegal., Locke E; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA., Njuguna PW; PATH Center for Vaccine Innovation and Access, Nairobi, Kenya. Electronic address: pnjuguna@path.org. |
| Source: | The Lancet. Global health [Lancet Glob Health] 2025 Dec; Vol. 13 (12), pp. e2122-e2132. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Equivalence Trial |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101613665 Publication Model: Print Cited Medium: Internet ISSN: 2214-109X (Electronic) Linking ISSN: 2214109X NLM ISO Abbreviation: Lancet Glob Health Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41240950 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ndiaye+BP%22">Ndiaye BP</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Koech+L%22">Koech L</searchLink>; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Mercer+LD%22">Mercer LD</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Aponte+JJ%22">Aponte JJ</searchLink>; PATH Center for Vaccine Innovation and Access, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cisse+B%22">Cisse B</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Riziki+F%22">Riziki F</searchLink>; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Keter+W%22">Keter W</searchLink>; Kenya Medical Research Institute-US Army Medical Research Directorate Africa-HJF Medical Research International, Kericho, Kenya.<br /><searchLink fieldCode="AU" term="%22Eaton+N%22">Eaton N</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Diye+S%22">Diye S</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Wade+D%22">Wade D</searchLink>; Institute for Health Research - Epidemiological Surveillance and Training, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Bob+NS%22">Bob NS</searchLink>; Institut Pasteur de Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Raine+MG%22">Raine MG</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Her+H%22">Her H</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Erdem+R%22">Erdem R</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Cassels+FJ%22">Cassels FJ</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Dia+M%22">Dia M</searchLink>; Institut Pasteur de Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Baik+YO%22">Baik YO</searchLink>; EuBiologics, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Fall+G%22">Fall G</searchLink>; Institut Pasteur de Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Locke+E%22">Locke E</searchLink>; PATH Center for Vaccine Innovation and Access, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Njuguna+PW%22">Njuguna PW</searchLink>; PATH Center for Vaccine Innovation and Access, Nairobi, Kenya. Electronic address: pnjuguna@path.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101613665%22">The Lancet. Global health</searchLink> [Lancet Glob Health] 2025 Dec; Vol. 13 (12), pp. e2122-e2132. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Equivalence Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101613665 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2214-109X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222214109X%22">2214109X </searchLink><i>NLM ISO Abbreviation: </i>Lancet Glob Health <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41240950 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S2214-109X(25)00330-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2122 Titles: – TitleFull: Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ndiaye BP – PersonEntity: Name: NameFull: Koech L – PersonEntity: Name: NameFull: Mercer LD – PersonEntity: Name: NameFull: Aponte JJ – PersonEntity: Name: NameFull: Cisse B – PersonEntity: Name: NameFull: Riziki F – PersonEntity: Name: NameFull: Keter W – PersonEntity: Name: NameFull: Eaton N – PersonEntity: Name: NameFull: Diye S – PersonEntity: Name: NameFull: Wade D – PersonEntity: Name: NameFull: Bob NS – PersonEntity: Name: NameFull: Raine MG – PersonEntity: Name: NameFull: Her H – PersonEntity: Name: NameFull: Kim S – PersonEntity: Name: NameFull: Erdem R – PersonEntity: Name: NameFull: Lee C – PersonEntity: Name: NameFull: Cassels FJ – PersonEntity: Name: NameFull: Park Y – PersonEntity: Name: NameFull: Dia M – PersonEntity: Name: NameFull: Baik YO – PersonEntity: Name: NameFull: Fall G – PersonEntity: Name: NameFull: Locke E – PersonEntity: Name: NameFull: Njuguna PW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2214-109X Numbering: – Type: volume Value: 13 – Type: issue Value: 12 Titles: – TitleFull: The Lancet. Global health Type: main |
| ResultId | 1 |